Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.

Whittum-Hudson JA, An LL, Saltzman WM, Prendergast RA, MacDonald AB.

Nat Med. 1996 Oct;2(10):1116-21.

PMID:
8837610
2.

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.

Whittum-Hudson JA, Rudy D, Gèrard H, Vora G, Davis E, Haller PK, Prattis SM, Hudson AP, Saltzman WM, Stuart ES.

Vaccine. 2001 Jul 16;19(28-29):4061-71.

PMID:
11427283
3.

Biochemical and functional antigenic mimicry by a polyclonal anti-idiotypic antibody for chlamydial exoglycolipid antigen.

An LL, Hudson AP, Prendergast RA, O'Brien TP, Stuart ES, Whittum-Hudson JA, MacDonald AB.

Pathobiology. 1997;65(5):229-40. Erratum in: Pathobiology 1998;66(1):48.

PMID:
9459493
4.

A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.

Campos M, Pal S, O'Brien TP, Taylor HR, Prendergast RA, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1477-91.

PMID:
7601629
6.

Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.

Badamchi-Zadeh A, McKay PF, Holland MJ, Paes W, Brzozowski A, Lacey C, Follmann F, Tregoning JS, Shattock RJ.

PLoS One. 2015 Oct 26;10(10):e0141209. doi: 10.1371/journal.pone.0141209. eCollection 2015.

7.

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.

Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD.

J Exp Med. 1998 Sep 7;188(5):809-18.

9.

Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.

Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K.

Vaccine. 2006 Feb 20;24(8):1213-24. Epub 2005 Sep 12.

PMID:
16194585
10.

Attempted oral immunization with chlamydial lipopolysaccharide subunit vaccine.

Taylor HR, Prendergast RA.

Invest Ophthalmol Vis Sci. 1987 Oct;28(10):1722-6.

PMID:
3308760
11.

Vaccines against Chlamydia: approaches and progress.

Stagg AJ.

Mol Med Today. 1998 Apr;4(4):166-73. Review.

PMID:
9572058
12.
13.

Oral immunization with chlamydial major outer membrane protein (MOMP).

Taylor HR, Whittum-Hudson J, Schachter J, Caldwell HD, Prendergast RA.

Invest Ophthalmol Vis Sci. 1988 Dec;29(12):1847-53.

PMID:
3192374
14.

A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.

Knight SC, Iqball S, Woods C, Stagg A, Ward ME, Tuffrey M.

Immunology. 1995 May;85(1):8-15.

15.

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.

Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU.

Vaccine. 2003 Apr 2;21(15):1694-703.

PMID:
12639492
16.

A Role for the glycolipid exoantigen (GLXA) in chlamydial infectivity.

Vora GJ, Stuart ES.

Curr Microbiol. 2003 Mar;46(3):217-23.

PMID:
12567246
19.

Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.

Li W, Murthy AK, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP.

J Immunol. 2008 Mar 1;180(5):3375-82.

20.

Towards a Chlamydia trachomatis vaccine: how close are we?

Cochrane M, Armitage CW, O'Meara CP, Beagley KW.

Future Microbiol. 2010 Dec;5(12):1833-56. doi: 10.2217/fmb.10.148. Review.

PMID:
21155665

Supplemental Content

Support Center